Testing effectiveness (Phase 2)UnknownNCT00003827What this trial is testingCombination Chemotherapy in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes ALZA 25
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT00274820What this trial is testingArsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative DisorderWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more Case Comprehensive Cancer Center 15
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Early research (Phase 1)Active Not RecruitingNCT02890329What this trial is testingIpilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forPreviously Treated Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia, Myelodysplasia-Related+5 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Ended earlyNCT01465386What this trial is testingBortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in RemissionWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Myeloblastic Leukemia Without Maturation (M1)+9 more Fred Hutchinson Cancer Center 6
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00352001What this trial is testingLenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Mikkael Sekeres MD 37
Large-scale testing (Phase 3)UnknownNCT00006045What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaWho this might be right forLeukemia Facet Biotech
Early research (Phase 1)Study completedNCT01174888What this trial is testingPhase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia FollowingMyelodysplastic Syndrome+8 more Alison Walker 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544466What this trial is testingHelical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological MalignanciesWho this might be right forLeukemiaMyelodysplastic Syndromes City of Hope Medical Center 75
Testing effectiveness (Phase 2)Ended earlyNCT03303950What this trial is testingAllogeneic Stem Cell Transplantation for Multiple Myeloma and MyelofibrosisWho this might be right forAnemiaASXL1 Gene MutationEZH2 Gene Mutation+7 more University of Utah 6
Testing effectiveness (Phase 2)Looking for participantsNCT05807932What this trial is testingVenetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAMLWho this might be right forMyelodysplastic SyndromesSecondary Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia Heinrich-Heine University, Duesseldorf 38
Early research (Phase 1)Active Not RecruitingNCT04328844What this trial is testingAssess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersWho this might be right forSolid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more iOnctura 210
Testing effectiveness (Phase 2)Study completedNCT00083187What this trial is testingVNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk MyelodysplasiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Vion Pharmaceuticals 230
Early research (Phase 1)Ended earlyNCT00234000What this trial is testingAzacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center 1
Not applicableStudy completedNCT00584428What this trial is testingHigh Dose Chemo With Autologous BMT for Treatment of Metastatic Breast CancerWho this might be right forBreast Neoplasms University of Oklahoma 61
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Large-scale testing (Phase 3)Study completedNCT00004208What this trial is testingAntithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndromes Swiss Cancer Institute 86